- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: bimatoprost Formulation B
Total 8149 results
-
Amneal Pharmaceuticals, LLCCBCC Global ResearchRecruitingOcular Hypertension | Glaucoma, Open-AngleUnited States
-
Mankind Pharma LimitedCBCC Global ResearchCompleted
-
AstraZenecaCompletedParkinson's DiseaseUnited Kingdom
-
Lyndra Inc.TerminatedHealthy | Gastric RetentionUnited Kingdom
-
Sanofi Pasteur, a Sanofi CompanyGlaxoSmithKlineCompletedCOVID-19Honduras, United States, Australia, France, New Zealand, Spain, United Kingdom
-
Northwestern UniversityAllerganCompletedIntraocular Pressure | Nail Growth CessationUnited States
-
Manistee PartnersUnknownMigraine Disorders | Headache DisordersUnited States
-
TakedaCompletedHealthy VolunteersUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
Laboratoires TheaCompletedOcular Hypertension GlaucomaBulgaria
-
Innovative MedicalCompletedGlaucomaUnited States
-
Julie DawsonCompletedOpen Angle Glaucoma and CataractUnited Kingdom
-
AllerganCompleted
-
Centre de recherche du Centre hospitalier universitaire...UnknownOcular Hypertension | Primary GlaucomaCanada
-
Jonsson Comprehensive Cancer CenterWithdrawn
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
PfizerCompleted
-
AllerganCompletedHypotrichosisUnited States, United Kingdom
-
University of California, San FranciscoCompletedAlopecia AreataUnited States
-
Tulane UniversityAllerganCompleted
-
Gian Sagar Medical College and HospitalWithdrawnVitiligo | Repigmentation
-
AllerganCompletedOcular Hypertension | Open-Angle GlaucomaBelgium
-
AllerganCompletedOcular Hypertension | Glaucoma, Primary Open AngleGermany
-
AllerganCompletedLong-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionOcular Hypertension | GlaucomaSpain, France, Belgium, Israel, United Kingdom, Poland, Italy, Czechia, Germany, Hungary
-
Baylor College of MedicineCompletedHookworm Infection | Hookworm DiseaseBrazil
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleAustria
-
AllerganCompletedEyelashesUnited States, Canada
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States
-
Innovative MedicalCompleted
-
AllerganCompletedAlopecia Areata | Eyelash HypotrichosisUnited States, Brazil
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleSwitzerland
-
AllerganCompletedHypotrichosisUnited States
-
Midwest Center for Metabolic and Cardiovascular...Pharmavite LLCCompletedBioavailabilityUnited States
-
GenfitNaturalpha; SGS Aster S.A.S.CompletedCardiovascular Diseases | Metabolic Diseases | Diabetes Mellitus, Type 2 | Type 2 Diabetes | Dyslipidemia | ObeseFrance
-
ForSight Vision5, Inc.CompletedOcular Hypertension | Primary Open-Angle GlaucomaUnited States
-
Association for Innovation and Biomedical Research...European Vision Institute Clinical Research NetworkCompletedOcular Hypertension | GlaucomaUnited Kingdom, Switzerland, Belgium, Italy, Portugal, Austria
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Larissa University HospitalCompletedOcular Hypertension | GlaucomaGreece
-
Boehringer IngelheimCompleted
-
Otsuka Pharmaceutical Development & Commercialization...PRA Health SciencesCompletedSchizophrenia | Bipolar DisorderUnited States
-
Medicines for Malaria VentureQuotient ClinicalCompleted
-
Boehringer IngelheimTerminated
-
Vistakon PharmaceuticalsCompletedOcular Hypertension | Open-angle GlaucomaUnited States
-
LEO PharmaCompletedActinic KeratosisCanada, United States
-
GlaxoSmithKlineCompleted
-
Idorsia Pharmaceuticals Ltd.CompletedSafety, Tolerability, Pharmacokinetics and PharmacodynamicsFrance
-
ForSight Vision5, Inc.CompletedOcular Hypertension | Primary Open-Angle GlaucomaUnited States
-
Boehringer IngelheimRecruitingHidradenitis SuppurativaUnited States, Korea, Republic of, Israel, Spain, Australia, Japan, Italy, Germany, Denmark, Belgium, Lithuania, China, Canada, Malaysia, Singapore, New Zealand, France, Mexico, Netherlands, Greece, United Kingdom, Bulgaria, Philipp... and more